Keyword: Leonard Schleifer

Regeneron CEO Len Schleifer has been at or near the top of the biopharma executive-pay charts for years. That’s still the case for 2016, but not by as wide a margin.

Roche CEO Severin Schwan and Novartis chief Joe Jimenez likely won't rank among biopharma's highest-paid this year. But at least they're on par with each other at almost 12M francs each.

Once again, Regeneron CEO Leonard Schleifer and his R&D chief George Yancopoulos are among the highest-paid executives in the industry, with $47.5 million and $40.3 in 2015 compensation.